Evotec SE and EQRx, a new type of pharmaceutical company committed to developing and important new medicines to patients at radically lower prices, entered a collaboration to design, discover and develop new therapeutic options for patients. The collaboration aims to accelerate EQRx’s pipeline by leveraging Evotec’s data-driven, integrated R&D-platform, applied across different drug modalities and therapeutic areas. This approach aims to expedite the invention and development of ...